Attached files
| file | filename |
|---|---|
| EX-23.2 - EX-23.2 - Evofem Biosciences, Inc. | d540932dex232.htm |
| EX-5.1 - EX-5.1 - Evofem Biosciences, Inc. | d540932dex51.htm |
| EX-4.10 - EX-4.10 - Evofem Biosciences, Inc. | d540932dex410.htm |
| EX-4.9 - EX-4.9 - Evofem Biosciences, Inc. | d540932dex49.htm |
| EX-1.1 - EX-1.1 - Evofem Biosciences, Inc. | d540932dex11.htm |
| S-1 - FORM S-1 - Evofem Biosciences, Inc. | d540932ds1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated February 28, 2018, relating to the consolidated financial statements of Evofem Biosciences, Inc. and subsidiaries (the “Company”) (which report expresses an unqualified opinion and includes an explanatory paragraph relating to the Company’s ability to continue as a going concern) appearing in the Current Report on Form 8-K/A of the Company dated April 6, 2018, and to the reference to us under the heading “Experts” in the prospectus, which is part of this Registration Statement.
/s/ DELOITTE & TOUCHE LLP
San Diego, California
May 15, 2018